ARS Pharmaceuticals

FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
FDA Regulatory Gauntlet Isn’t Getting Any Easier, Just Ask These Companies
BioSpace
FDA
ARS Pharmaceuticals
Novartis
Taysha
Alvotech
Intarcia
Flag link:
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
Forbes
ARS Pharmaceuticals
FDA
epinephrine nasal spray
Neffy
allergic reactions
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative
First epinephrine nasal spray clears key FDA hurdle, promising needle-free alternative
CBS News
ARS Pharmaceuticals
FDA
epinephrine nasal spray
Neffy
Flag link:
Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative
Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative
Geekwire
Silverback Therapeutics
M&A
ARS Pharmaceuticals
Flag link: